Development of Blueberry-Derived Extracellular Nanovesicles for Immunomodulatory Therapy

Development of Blueberry-Derived Extracellular Nanovesicles for Immunomodulatory Therapy

Over the past decade, there has been a significant expansion in the development of plant-derived extracellular nanovesicles (EVs) as an effective drug delivery system for precision therapy. However, the lack of effective methods for the isolation and characterization of plant EVs hampers progress in...

Full description

Bibliographic Details
Main Authors: Tuong Ngoc-Gia Nguyen, Cuong Viet Pham, Rocky Chowdhury, Shweta Patel, Satendra Kumar Jaysawal, Yingchun Hou, Huo Xu, Lee Jia, Andrew Duan, Phuong Ha-Lien Tran, Wei Duan
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pharmaceutics
Subjects:
plant EV
biomarker
pathogen-related proteins
class I chitinase
drug delivery
immunomodulatory
Online Access:https://www.mdpi.com/1999-4923/15/8/2115

Internet

https://www.mdpi.com/1999-4923/15/8/2115

Similar Items